Literature DB >> 9627748

The "incredible shrinking" P50 event-related potential.

G A Light1, D L Braff.   

Abstract

The P50 component of the auditory evoked response has been utilized in studies of sensory gating in schizophrenia for over 15 years. As P50 gating studies have had a greater impact in neuroscience research, investigators have refined several key variables (e.g., filtering) to enhance signal-to-noise ratios. A comprehensive review of P50 reports suggests P50 amplitude has been steadily decreasing over the years. Certain methodological "advances" are suggested as key reasons for this apparent reduction in P50 amplitude. Gating studies continue to yield interesting findings in neuropsychiatric research, especially when ratio vs. absolute difference scores are used.

Entities:  

Mesh:

Year:  1998        PMID: 9627748     DOI: 10.1016/s0006-3223(98)00118-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  Electroencephalography (EEG) and event-related potentials (ERPs) with human participants.

Authors:  Gregory A Light; Lisa E Williams; Falk Minow; Joyce Sprock; Anthony Rissling; Richard Sharp; Neal R Swerdlow; David L Braff
Journal:  Curr Protoc Neurosci       Date:  2010-07

2.  P50 inhibitory sensory gating in schizophrenia: analysis of recent studies.

Authors:  Robert Freedman; Amanda M Olsen-Dufour; Ann Olincy
Journal:  Schizophr Res       Date:  2020-02-13       Impact factor: 4.939

3.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 4.  Schizophrenia: neural mechanisms for novel therapies.

Authors:  Akira Sawa; Solomon H Snyder
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

Review 5.  Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?

Authors:  S Bender; M Weisbrod; F Resch
Journal:  J Neural Transm (Vienna)       Date:  2007-05-21       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.